Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 06:22 am Sale | 2021-12-31 | 13G | Aerovate Therapeutics, Inc. AVTE | Citadel Advisors LLC | 45,642 6.500% | -791 (-1.70%) | Filing History |
| 2021-11-05 4:38 pm Purchase | 2021-07-02 | 13D | Aerovate Therapeutics, Inc. AVTE | Atlas Venture Associates XII LLC | 88,682 12.700% | 88,682 (New Position) | Filing History |
| 2021-07-13 1:49 pm Purchase | 2021-07-02 | 13D | Aerovate Therapeutics, Inc. AVTE | Sofinnova Venture Partners X, L.P. ("SVP X") | 107,431 16.300% | 107,431 (New Position) | Filing History |
| 2021-07-12 5:13 pm Purchase | 2021-07-02 | 13D | Aerovate Therapeutics, Inc. AVTE | RA CAPITAL MANAGEMENT L.P. | 236,114 33.900% | 236,114 (New Position) | Filing History |
| 2021-07-12 4:19 pm Purchase | 2021-07-02 | 13G | Aerovate Therapeutics, Inc. AVTE | Cormorant Asset Management, LP | 58,020 8.320% | 58,020 (New Position) | Filing History |
| 2021-07-12 4:03 pm Purchase | 2021-07-02 | 13G | Aerovate Therapeutics, Inc. AVTE | Citadel Advisors LLC | 46,434 6.700% | 46,434 (New Position) | Filing History |